Securities code: Jiangsu Kuangshun Photosensitivity New-Material Stock Co.Ltd(300537) securities abbreviation: Jiangsu Kuangshun Photosensitivity New-Material Stock Co.Ltd(300537) Announcement No.: 2022040 Jiangsu Kuangshun Photosensitivity New-Material Stock Co.Ltd(300537)
On the issue of A-Shares to specific objects and the dilution of immediate return on the company’s main
Impact of financial indicators and announcement of measures taken by the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Important:
1. The following analysis and description of the main financial indicators of Jiangsu Kuangshun Photosensitivity New-Material Stock Co.Ltd(300537) (hereinafter referred to as “the company”) after issuing A-Shares to specific objects do not constitute the profit forecast of the company. Investors should not make investment decisions only based on such analysis and description. If investors make investment decisions based on this, the company will not bear any responsibility.
2. The measures to fill in the return and the commitments of relevant commitment subjects formulated by the company this time do not guarantee the company’s future profits. Please pay attention to investors and pay attention to investment risks.
Jiangsu Kuangshun Photosensitivity New-Material Stock Co.Ltd(300537) (hereinafter referred to as “the company” and “the company”) deliberated and adopted the proposal on Revising the company’s plan for issuing A-Shares to specific objects in 2021 and other relevant proposals at the 16th meeting of the Fourth Board of directors. According to the opinions of the general office of the State Council on Further Strengthening the protection of the legitimate rights and interests of small and medium-sized investors in the capital market (GBF [2013] No. 110) The relevant requirements of laws, regulations and normative documents such as several opinions of the State Council on further promoting the healthy development of the capital market (GF [2014] No. 17) and the guiding opinions on matters related to initial public offering, refinancing and dilution of immediate return of major asset restructuring (announcement [2015] No. 31 of China Securities Regulatory Commission) to protect the interests of small and medium-sized investors, The company has carefully analyzed the impact of the issuance of A-share shares to specific objects on the dilution of immediate return, and put forward specific measures to fill the return. The relevant subjects have made commitments that the company’s measures to fill the return can be effectively implemented, as follows:
1、 The impact of diluting the immediate return of A-Shares issued to specific objects on the company’s main financial indicators
(I) assumptions
The company’s calculation of main financial indicators in 2022 is based on the following assumptions:
1. It is assumed that there are no major adverse changes in the macroeconomic environment and the industry in which the company is located;
2、 It is assumed that the company will complete this offering to specific objects at the end of August 2022 (the completion time is only used to calculate the impact of this issuance on the immediate return, and does not constitute a commitment to the actual completion time. Investors should not make investment decisions based on this. If investors make investment decisions based on this, and cause losses, the company will not be liable for compensation. Finally, the actual number of shares issued after the examination and approval of Shenzhen Stock Exchange and the registration and approval of China Securities Regulatory Commission shall prevail).
3. It is assumed that the total amount of funds raised from this issuance to specific objects is 570 million yuan, without considering the impact of deducting issuance expenses; Assuming that the maximum number of A-Shares issued to specific objects this time is 57908275 shares, the final number of shares issued is subject to the registration document of the CSRC on this issuance to specific objects.
4. In 2021, the net profit attributable to the shareholders of the parent company and the net profit attributable to the shareholders of the parent company after deducting non recurring profits and losses were -4105622 million yuan and -4071331 million yuan respectively. The impact of the company’s provision for impairment of large assets on the net profit in 2021 is -3501130 million yuan. After excluding this impact, the net profit attributable to the shareholders of the parent company and the net profit attributable to the shareholders of the parent company after deducting non recurring profits and losses in 2021 are -604492 million yuan and -570201 million yuan respectively.
It is assumed that the company does not need to make provision for large asset impairment in 2022, and the net profit attributable to the shareholders of the parent company in 2022 and the net profit attributable to the shareholders of the parent company after deducting non recurring profits and losses are calculated at 0% and 15% on the basis of 2021 (excluding the impact of making provision for large asset impairment on the net profit) The performance growth rate of 25% is calculated separately (the above growth rate does not represent the company’s profit forecast for future profits, but is only used to calculate the impact of the diluted immediate return of this issuance on the main indicators. Investors should not make investment decisions based on this. If investors make investment decisions based on this, the company will not be liable for losses caused by the investment decisions);
5. The impact of this issuance on other production, operation and financial conditions of the company (such as financial expenses and investment income) is not considered;
6. As of December 31, 2021, the owner’s equity attributable to the listed company was 693023700 yuan; It is assumed that the owner’s equity attributable to the listed company as of December 31, 2022 = the owner’s equity attributable to the listed company at the beginning of 2022 + the net profit attributable to the listed company in 2022 + the owner’s equity increased by the issuance of new shares. It is assumed that when predicting the net assets of the company after issuance, the impact of cash dividends and other factors other than raised funds and net profits on the net assets is not considered;
7. The impact of restricted shares and stock options on the company will not be considered temporarily;
8. It is assumed that except for this issuance and the above matters, the company will not carry out other acts that will affect or potentially affect the total share capital of the company;
9. Do not consider the impact of bank interest generated before the raised funds are utilized;
10. The above assumptions are only to calculate the impact of the diluted immediate return of this issuance on the company’s main financial indicators, and do not represent the company’s commitment to the profitability and cash dividends in 2022, nor the company’s judgment on the operation and trend in 2022.
(II) impact on main financial indicators
Based on the above assumptions, the company calculated the impact of the diluted immediate return on the company’s main financial indicators, as follows:
Unit: 10000 yuan
Year 2021 / year 2022 / December 31, 2022
This issue was not considered in 2021
December 31
Hypothetical scenario (1): the net profit in 2022 is the same as that in 2021 (excluding the impact of withdrawing large asset impairment reserves on the net profit)
Total share capital (10000 shares) 193027619302762509359
Net profit of -4105622 -604492 -604492 attributable to the owner of the parent company in the current period (10000 yuan) deduction attributable to the owner of the parent company in the current period
Unless the net profit of recurring profit and loss (10000 -4071331 -570201 -570201 yuan)
Owner’s rights attributable to the parent company at the beginning of the period 1102996069302376930237 (10000 yuan)
At the end of the period, the owner’s right attributable to the parent company was 6930237, 6325744 and 12025744 yuan (10000 yuan)
Basic earnings per share (yuan / share) -2.13 -0.31 -0.28
Basic earnings per share after deducting non recurring profits and losses -2.11 -0.30 -0.27 (yuan / share)
Net assets per share (yuan) 3.59 3.28 4.79
Weighted average return on net assets -45.73% – 9.12% – 7.09%
Assumption of weighted average return on net assets of – 45.35% – 8.60% – 6.69% after deducting non recurring profits and losses (2): the net profit in 2022 will increase by 15% compared with that in 2021 (excluding the impact of the provision for impairment of large assets on the net profit)
Total share capital (10000 shares) 193027619302762509359
Net profit of -4105622 -513819 -513819 attributable to the owner of the parent company in the current period (10000 yuan) deduction attributable to the owner of the parent company in the current period
Unless the net profit of recurring profit and loss (10000 -4071331 -484671 -484671 yuan)
Owner’s rights attributable to the parent company at the beginning of the period 1102996069302376930237 (10000 yuan)
At the end of the period, the owner’s right attributable to the parent company was 6930237, 6416418 and 12116418 yuan (10000 yuan)
Basic earnings per share (yuan / share) -2.13 -0.27 -0.24
Basic earnings per share after deducting non recurring gains and losses -2.11 -0.25 -0.23 (yuan / share)
Net assets per share (yuan) 3.59 3.32 4.83
Weighted average return on net assets -45.73% – 7.70% – 5.99%
Assumption of weighted average return on net assets of – 45.35% – 7.26% – 5.65% after deducting non recurring profits and losses (3): the net profit in 2022 will increase by 25% compared with that in 2021 (excluding the impact of the provision for impairment of large assets on the net profit)
Total share capital (10000 shares) 193027619302762509359
Net profit of -4105622 -453369 -453369 (10000 yuan) attributable to the owner of the parent company in the current period
Unless the net profit of recurring profit and loss (10000 -4071331 -427651 -427651 yuan)
The owner’s equity at the beginning of the period is RMB 1 Hainan Shuangcheng Pharmaceuticals Co.Ltd(002693) 7 million (attributable to the parent company)
At the end of the period, the owner’s right attributable to the parent company was 6930237, 6476867 and 12176867 yuan (10000 yuan)
Basic earnings per share (yuan / share) -2.13 -0.23 -0.21
Basic earnings per share excluding non recurring gains and losses -2.11 -0.22 -0.20 (yuan / share)
Net assets per share (yuan) 3.59 3.36 4.85
Weighted average return on net assets -45.73% – 6.76% – 5.27%
After deducting non recurring profits and losses, the weighted average return on net assets is – 45.35% – 6.38% – 4.97%
Note: 1. The above calculation does not take into account the impact on the company’s operation after the funds raised by this issuance are received.
2. The weighted return on assets per share and the rate of return on net assets per share calculated in accordance with the provisions of Part 9 of the disclosure rules of the company (revised 2010). 3. Basic earnings per share = net profit attributable to the owners of the parent company / total share capital in the current period; Basic earnings per share after deducting non recurring gains and losses = net profit after deducting non recurring gains and losses attributable to the owner of the parent company / total share capital in the current period; each
